Gender differences in the prevalence of diabetes mellitus in chronic hospitalized patients with schizophrenia on long-term antipsychotics

被引：17

作者：

Chen, Da Chun ^{[3
]}

Zhou, Ming Ai ^{[2
]}

Zhou, Dong Hao ^{[2
]}

Xiu, Mel Hong ^{[3
]}

Wu, Gui Ying ^{[1
]}

Kosten, Thomas R. ^{[1
]}

Zhang, Xiang Yang ^{[1
,3
]}

机构：

[1] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA

[2] LinYi Chinese Med Hosp, Dept Immunol & Allergol, Linyi, Shandong, Peoples R China

[3] Beijing HuiLongGuan Hosp, Ctr Biol Psychiat, Beijing, Peoples R China

来源：

PSYCHIATRY RESEARCH | 2011年 / 186卷 / 2-3期

关键词：

Schizophrenia; Gender differences; Diabetes mellitus; HORMONE REPLACEMENT THERAPY; IMPAIRED FASTING GLUCOSE; 2ND-GENERATION ANTIPSYCHOTICS; METABOLIC ABNORMALITIES; TOLERANCE; INSULIN; RISK;

D O I：

10.1016/j.psychres.2010.07.054

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

Gender-specific relationships between diabetes mellitus (DM) and schizophrenia have previously received little systematic study. The results showed that the overall DM prevalence was 20% with rates of 17% (58/343) in males and 27% (46/172) in females (p<0.01). Furthermore, increased body mass index (BMI), abdominal obesity and antipsychotic types were predictors of diabetes in these chronic schizophrenic patients. (C) 2010 Elsevier Ireland Ltd. All rights reserved.

引用

页码：451 / 453

页数：3

共 20 条

[1] Risk of treatment-emergent diabetes Mellitus in patients receiving antipsychotics [J].

Citrome, Leslie L. ;

Holt, Richard I. G. ;

Zachry, Woodie M. ;

Clewell, Jerry D. ;

Orth, Paul A. ;

Karagianis, Jamie L. ;

Hoffmann, Vicki Poole .

ANNALS OF PHARMACOTHERAPY, 2007, 41 (10) :1593-1603

[2] Applicability of the oral glucose tolerance test in assessing prevalence and incidence of diabetes mellitus in schizophrenia [J].

Cohen, Dan .

JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (08) :1307-1308

[3] Metabolic abnormalities associated with second generation antipsychotics: fact or fiction? Development of guidelines for screening and monitoring [J].

De Hert, M ;

van Eyck, D ;

De Nayer, A .

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2006, 21 :S11-S15

[4] Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication [J].

De Hert, MA ;

van Winkel, R ;

Van Eyck, D ;

Hanssens, L ;

Wampers, M ;

Scheen, A ;

Peuskens, J .

SCHIZOPHRENIA RESEARCH, 2006, 83 (01) :87-93

[5] Prevalence and correlates of diabetes in national schizophrenia samples [J].

Dixon, L ;

Weiden, P ;

Delahanty, J ;

Goldberg, R ;

Postrado, L ;

Lucksted, A ;

Lehman, A .

SCHIZOPHRENIA BULLETIN, 2000, 26 (04) :903-912

[6] Effect of postmenopausal hormone therapy on glucose and insulin concentrations [J].

Espeland, MA ;

Hogan, PE ;

Fineberg, SE ;

Howard, G ;

Schrott, H ;

Waclawiw, MA ;

Bush, TL .

DIABETES CARE, 1998, 21 (10) :1589-1595

[7] Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA) [J].

Gu, D ;

Reynolds, K ;

Duan, X ;

Xin, X ;

Chen, J ;

Wu, X ;

Mo, J ;

Whelton, PK ;

He, J .

DIABETOLOGIA, 2003, 46 (09) :1190-1198

[8] Atypical antipsychotic-induced diabetes mellitus - How strong is the evidence? [J].

Henderson, DC .

CNS DRUGS, 2002, 16 (02) :77-89

[9] Schizophrenia, the metabolic syndrome and diabetes [J].

Holt, RIG ;

Peveler, RC ;

Byrne, CD .

DIABETIC MEDICINE, 2004, 21 (06) :515-523

[10] Diabetes mellitus among outpatients receiving clozapine: Prevalence and clinical-demographic correlates [J].

Lamberti, JS ;

Costea, GO ;

Olson, D ;

Crilly, JF ;

Maharaj, K ;

Tu, X ;

Groman, A ;

Dietz, MB ;

Bushey, MP ;

Olivares, T ;

Wiener, K .

JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (07) :900-906

← 1 2 →